{"pmid":32098019,"title":"Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19).","text":["Communicating the Risk of Death from Novel Coronavirus Disease (COVID-19).","To understand the severity of infection for a given disease, it is common epidemiological practice to estimate the case fatality risk, defined as the risk of death among cases. However, there are three technical obstacles that should be addressed to appropriately measure this risk. First, division of the cumulative number of deaths by that of cases tends to underestimate the actual risk because deaths that will occur have not yet observed, and so the delay in time from illness onset to death must be addressed. Second, the observed dataset of reported cases represents only a proportion of all infected individuals and there can be a substantial number of asymptomatic and mildly infected individuals who are never diagnosed. Third, ascertainment bias and risk of death among all those infected would be smaller when estimated using shorter virus detection windows and less sensitive diagnostic laboratory tests. In the ongoing COVID-19 epidemic, health authorities must cope with the uncertainty in the risk of death from COVID-19, and high-risk individuals should be identified using approaches that can address the abovementioned three problems. Although COVID-19 involves mostly mild infections among the majority of the general population, the risk of death among young adults is higher than that of seasonal influenza, and elderly with underlying comorbidities require additional care.","J Clin Med","Kobayashi, Tetsuro","Jung, Sung-Mok","Linton, Natalie M","Kinoshita, Ryo","Hayashi, Katsuma","Miyama, Takeshi","Anzai, Asami","Yang, Yichi","Yuan, Baoyin","Akhmetzhanov, Andrei R","Suzuki, Ayako","Nishiura, Hiroshi","32098019"],"abstract":["To understand the severity of infection for a given disease, it is common epidemiological practice to estimate the case fatality risk, defined as the risk of death among cases. However, there are three technical obstacles that should be addressed to appropriately measure this risk. First, division of the cumulative number of deaths by that of cases tends to underestimate the actual risk because deaths that will occur have not yet observed, and so the delay in time from illness onset to death must be addressed. Second, the observed dataset of reported cases represents only a proportion of all infected individuals and there can be a substantial number of asymptomatic and mildly infected individuals who are never diagnosed. Third, ascertainment bias and risk of death among all those infected would be smaller when estimated using shorter virus detection windows and less sensitive diagnostic laboratory tests. In the ongoing COVID-19 epidemic, health authorities must cope with the uncertainty in the risk of death from COVID-19, and high-risk individuals should be identified using approaches that can address the abovementioned three problems. Although COVID-19 involves mostly mild infections among the majority of the general population, the risk of death among young adults is higher than that of seasonal influenza, and elderly with underlying comorbidities require additional care."],"journal":"J Clin Med","authors":["Kobayashi, Tetsuro","Jung, Sung-Mok","Linton, Natalie M","Kinoshita, Ryo","Hayashi, Katsuma","Miyama, Takeshi","Anzai, Asami","Yang, Yichi","Yuan, Baoyin","Akhmetzhanov, Andrei R","Suzuki, Ayako","Nishiura, Hiroshi"],"date":"2020-02-27T11:00:00Z","year":2020,"_id":"32098019","week":"20209|Feb 24 - Mar 01","doi":"10.3390/jcm9020580","keywords":["emerging infectious diseases","fatality","statistical estimation","virulence","virus"],"source":"PubMed","topics":["Epidemic Forecasting"],"weight":1,"_version_":1661359647480610816,"score":6.7365713,"similar":[{"pmid":32033064,"title":"The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights.","text":["The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights.","From 29 to 31 January 2020, a total of 565 Japanese citizens were evacuated from Wuhan, China on three chartered flights. All passengers were screened upon arrival in Japan for symptoms consistent with novel coronavirus (2019-nCoV) infection and tested for presence of the virus. Assuming that the mean detection window of the virus can be informed by the mean serial interval (estimated at 7.5 days), the ascertainment rate of infection was estimated at 9.2% (95% confidence interval: 5.0, 20.0). This indicates that the incidence of infection in Wuhan can be estimated at 20,767 infected individuals, including those with asymptomatic and mildly symptomatic infections. The infection fatality risk (IFR)-the actual risk of death among all infected individuals-is therefore 0.3% to 0.6%, which may be comparable to Asian influenza pandemic of 1957-1958.","J Clin Med","Nishiura, Hiroshi","Kobayashi, Tetsuro","Yang, Yichi","Hayashi, Katsuma","Miyama, Takeshi","Kinoshita, Ryo","Linton, Natalie M","Jung, Sung-Mok","Yuan, Baoyin","Suzuki, Ayako","Akhmetzhanov, Andrei R","32033064"],"abstract":["From 29 to 31 January 2020, a total of 565 Japanese citizens were evacuated from Wuhan, China on three chartered flights. All passengers were screened upon arrival in Japan for symptoms consistent with novel coronavirus (2019-nCoV) infection and tested for presence of the virus. Assuming that the mean detection window of the virus can be informed by the mean serial interval (estimated at 7.5 days), the ascertainment rate of infection was estimated at 9.2% (95% confidence interval: 5.0, 20.0). This indicates that the incidence of infection in Wuhan can be estimated at 20,767 infected individuals, including those with asymptomatic and mildly symptomatic infections. The infection fatality risk (IFR)-the actual risk of death among all infected individuals-is therefore 0.3% to 0.6%, which may be comparable to Asian influenza pandemic of 1957-1958."],"journal":"J Clin Med","authors":["Nishiura, Hiroshi","Kobayashi, Tetsuro","Yang, Yichi","Hayashi, Katsuma","Miyama, Takeshi","Kinoshita, Ryo","Linton, Natalie M","Jung, Sung-Mok","Yuan, Baoyin","Suzuki, Ayako","Akhmetzhanov, Andrei R"],"date":"2020-02-09T11:00:00Z","year":2020,"_id":"32033064","week":"20206|Feb 03 - Feb 09","doi":"10.3390/jcm9020419","keywords":["ascertainment","diagnosis","epidemiology","importation","statistical inference","travel"],"source":"PubMed","locations":["Japan","Japanese","Asian","Wuhan","China"],"countries":["Japan","China"],"countries_codes":["JPN|Japan","CHN|China"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1661359647203786752,"score":296.9675},{"pmid":32168464,"title":"Estimating Risk for Death from 2019 Novel Coronavirus Disease, China, January-February 2020.","text":["Estimating Risk for Death from 2019 Novel Coronavirus Disease, China, January-February 2020.","Since December 2019, when the first case of 2019 novel coronavirus disease (COVID-19) was identified in the city of Wuhan in the Hubei Province of China, the epidemic has generated tens of thousands of cases throughout China. As of February 28, 2020, the cumulative number of reported deaths in China was 2,858. We estimated the time-delay adjusted risk for death from COVID-19 in Wuhan, as well as for China excluding Wuhan, to assess the severity of the epidemic in the country. Our estimates of the risk for death in Wuhan reached values as high as 12% in the epicenter of the epidemic and approximately 1% in other, more mildly affected areas. The elevated death risk estimates are probably associated with a breakdown of the healthcare system, indicating that enhanced public health interventions, including social distancing and movement restrictions, should be implemented to bring the COVID-19 epidemic under control.","Emerg Infect Dis","Mizumoto, Kenji","Chowell, Gerardo","32168464"],"abstract":["Since December 2019, when the first case of 2019 novel coronavirus disease (COVID-19) was identified in the city of Wuhan in the Hubei Province of China, the epidemic has generated tens of thousands of cases throughout China. As of February 28, 2020, the cumulative number of reported deaths in China was 2,858. We estimated the time-delay adjusted risk for death from COVID-19 in Wuhan, as well as for China excluding Wuhan, to assess the severity of the epidemic in the country. Our estimates of the risk for death in Wuhan reached values as high as 12% in the epicenter of the epidemic and approximately 1% in other, more mildly affected areas. The elevated death risk estimates are probably associated with a breakdown of the healthcare system, indicating that enhanced public health interventions, including social distancing and movement restrictions, should be implemented to bring the COVID-19 epidemic under control."],"journal":"Emerg Infect Dis","authors":["Mizumoto, Kenji","Chowell, Gerardo"],"date":"2020-03-14T11:00:00Z","year":2020,"_id":"32168464","week":"202011|Mar 09 - Mar 15","doi":"10.3201/eid2606.200233","keywords":["2019 novel coronavirus disease","CFR","COVID-19","China","Hubei","SARS-CoV-2","Wuhan","case-fatality ratio","coronavirus","death","mortality","outbreak","respiratory diseases","risk","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1661359647930449922,"score":256.6011},{"pmid":32121356,"title":"Backcalculating the Incidence of Infection with COVID-19 on the Diamond Princess.","text":["Backcalculating the Incidence of Infection with COVID-19 on the Diamond Princess.","To understand the time-dependent risk of infection on a cruise ship, the Diamond Princess, I estimated the incidence of infection with novel coronavirus (COVID-19). The epidemic curve of a total of 199 confirmed cases was drawn, classifying individuals into passengers with and without close contact and crew members. A backcalculation method was employed to estimate the incidence of infection. The peak time of infection was seen for the time period from 2 to 4 February 2020, and the incidence has abruptly declined afterwards. The estimated number of new infections among passengers without close contact was very small from 5 February on which a movement restriction policy was imposed. Without the intervention from 5 February, it was predicted that the cumulative incidence with and without close contact would have been as large as 1373 (95% CI: 570, 2176) and 766 (95% CI: 587, 946) cases, respectively, while these were kept to be 102 and 47 cases, respectively. Based on an analysis of illness onset data on board, the risk of infection among passengers without close contact was considered to be very limited. Movement restriction greatly reduced the number of infections from 5 February onwards.","J Clin Med","Nishiura, Hiroshi","32121356"],"abstract":["To understand the time-dependent risk of infection on a cruise ship, the Diamond Princess, I estimated the incidence of infection with novel coronavirus (COVID-19). The epidemic curve of a total of 199 confirmed cases was drawn, classifying individuals into passengers with and without close contact and crew members. A backcalculation method was employed to estimate the incidence of infection. The peak time of infection was seen for the time period from 2 to 4 February 2020, and the incidence has abruptly declined afterwards. The estimated number of new infections among passengers without close contact was very small from 5 February on which a movement restriction policy was imposed. Without the intervention from 5 February, it was predicted that the cumulative incidence with and without close contact would have been as large as 1373 (95% CI: 570, 2176) and 766 (95% CI: 587, 946) cases, respectively, while these were kept to be 102 and 47 cases, respectively. Based on an analysis of illness onset data on board, the risk of infection among passengers without close contact was considered to be very limited. Movement restriction greatly reduced the number of infections from 5 February onwards."],"journal":"J Clin Med","authors":["Nishiura, Hiroshi"],"date":"2020-03-04T11:00:00Z","year":2020,"_id":"32121356","week":"202010|Mar 02 - Mar 08","doi":"10.3390/jcm9030657","keywords":["emerging infectious diseases","forecasting","incidence","statistical estimation","virus"],"source":"PubMed","topics":["Epidemic Forecasting"],"weight":1,"_version_":1661359647639994369,"score":254.84807},{"pmid":32075152,"title":"Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases.","text":["Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases.","The exported cases of 2019 novel coronavirus (COVID-19) infection that were confirmed outside China provide an opportunity to estimate the cumulative incidence and confirmed case fatality risk (cCFR) in mainland China. Knowledge of the cCFR is critical to characterize the severity and understand the pandemic potential of COVID-19 in the early stage of the epidemic. Using the exponential growth rate of the incidence, the present study statistically estimated the cCFR and the basic reproduction number-the average number of secondary cases generated by a single primary case in a naive population. We modeled epidemic growth either from a single index case with illness onset on 8 December, 2019 (Scenario 1), or using the growth rate fitted along with the other parameters (Scenario 2) based on data from 20 exported cases reported by 24 January 2020. The cumulative incidence in China by 24 January was estimated at 6924 cases (95% confidence interval [CI]: 4885, 9211) and 19,289 cases (95% CI: 10,901, 30,158), respectively. The latest estimated values of the cCFR were 5.3% (95% CI: 3.5%, 7.5%) for Scenario 1 and 8.4% (95% CI: 5.3%, 12.3%) for Scenario 2. The basic reproduction number was estimated to be 2.1 (95% CI: 2.0, 2.2) and 3.2 (95% CI: 2.7, 3.7) for Scenarios 1 and 2, respectively. Based on these results, we argued that the current COVID-19 epidemic has a substantial potential for causing a pandemic. The proposed approach provides insights in early risk assessment using publicly available data.","J Clin Med","Jung, Sung-Mok","Akhmetzhanov, Andrei R","Hayashi, Katsuma","Linton, Natalie M","Yang, Yichi","Yuan, Baoyin","Kobayashi, Tetsuro","Kinoshita, Ryo","Nishiura, Hiroshi","32075152"],"abstract":["The exported cases of 2019 novel coronavirus (COVID-19) infection that were confirmed outside China provide an opportunity to estimate the cumulative incidence and confirmed case fatality risk (cCFR) in mainland China. Knowledge of the cCFR is critical to characterize the severity and understand the pandemic potential of COVID-19 in the early stage of the epidemic. Using the exponential growth rate of the incidence, the present study statistically estimated the cCFR and the basic reproduction number-the average number of secondary cases generated by a single primary case in a naive population. We modeled epidemic growth either from a single index case with illness onset on 8 December, 2019 (Scenario 1), or using the growth rate fitted along with the other parameters (Scenario 2) based on data from 20 exported cases reported by 24 January 2020. The cumulative incidence in China by 24 January was estimated at 6924 cases (95% confidence interval [CI]: 4885, 9211) and 19,289 cases (95% CI: 10,901, 30,158), respectively. The latest estimated values of the cCFR were 5.3% (95% CI: 3.5%, 7.5%) for Scenario 1 and 8.4% (95% CI: 5.3%, 12.3%) for Scenario 2. The basic reproduction number was estimated to be 2.1 (95% CI: 2.0, 2.2) and 3.2 (95% CI: 2.7, 3.7) for Scenarios 1 and 2, respectively. Based on these results, we argued that the current COVID-19 epidemic has a substantial potential for causing a pandemic. The proposed approach provides insights in early risk assessment using publicly available data."],"journal":"J Clin Med","authors":["Jung, Sung-Mok","Akhmetzhanov, Andrei R","Hayashi, Katsuma","Linton, Natalie M","Yang, Yichi","Yuan, Baoyin","Kobayashi, Tetsuro","Kinoshita, Ryo","Nishiura, Hiroshi"],"date":"2020-02-21T11:00:00Z","year":2020,"_id":"32075152","week":"20208|Feb 17 - Feb 23","doi":"10.3390/jcm9020523","keywords":["censoring","emerging infectious diseases","importation","migration","mortality","travel"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1661359647336955906,"score":215.67905},{"pmid":32079150,"title":"Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data.","text":["Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data.","The geographic spread of 2019 novel coronavirus (COVID-19) infections from the epicenter of Wuhan, China, has provided an opportunity to study the natural history of the recently emerged virus. Using publicly available event-date data from the ongoing epidemic, the present study investigated the incubation period and other time intervals that govern the epidemiological dynamics of COVID-19 infections. Our results show that the incubation period falls within the range of 2-14 days with 95% confidence and has a mean of around 5 days when approximated using the best-fit lognormal distribution. The mean time from illness onset to hospital admission (for treatment and/or isolation) was estimated at 3-4 days without truncation and at 5-9 days when right truncated. Based on the 95th percentile estimate of the incubation period, we recommend that the length of quarantine should be at least 14 days. The median time delay of 13 days from illness onset to death (17 days with right truncation) should be considered when estimating the COVID-19 case fatality risk.","J Clin Med","Linton, Natalie M","Kobayashi, Tetsuro","Yang, Yichi","Hayashi, Katsuma","Akhmetzhanov, Andrei R","Jung, Sung-Mok","Yuan, Baoyin","Kinoshita, Ryo","Nishiura, Hiroshi","32079150"],"abstract":["The geographic spread of 2019 novel coronavirus (COVID-19) infections from the epicenter of Wuhan, China, has provided an opportunity to study the natural history of the recently emerged virus. Using publicly available event-date data from the ongoing epidemic, the present study investigated the incubation period and other time intervals that govern the epidemiological dynamics of COVID-19 infections. Our results show that the incubation period falls within the range of 2-14 days with 95% confidence and has a mean of around 5 days when approximated using the best-fit lognormal distribution. The mean time from illness onset to hospital admission (for treatment and/or isolation) was estimated at 3-4 days without truncation and at 5-9 days when right truncated. Based on the 95th percentile estimate of the incubation period, we recommend that the length of quarantine should be at least 14 days. The median time delay of 13 days from illness onset to death (17 days with right truncation) should be considered when estimating the COVID-19 case fatality risk."],"journal":"J Clin Med","authors":["Linton, Natalie M","Kobayashi, Tetsuro","Yang, Yichi","Hayashi, Katsuma","Akhmetzhanov, Andrei R","Jung, Sung-Mok","Yuan, Baoyin","Kinoshita, Ryo","Nishiura, Hiroshi"],"date":"2020-02-22T11:00:00Z","year":2020,"_id":"32079150","week":"20208|Feb 17 - Feb 23","doi":"10.3390/jcm9020538","keywords":["distribution","emerging infectious diseases","epidemiology","incubation period","virus"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1661359647390433282,"score":197.72127}]}